RSLBF (RaySearch Laboratories AB) YoY EBITDA Growth : 67.97% (As of Mar. 2025)

View and export this data going back to 2011. Start your Free Trial

What is RaySearch Laboratories AB YoY EBITDA Growth?

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months. RaySearch Laboratories AB's YoY EBITDA Growth for the quarter that ended in Mar. 2025 was 67.97%.

RaySearch Laboratories AB's EBITDA per Share for the three months ended in Mar. 2025 was $0.22.

RaySearch Laboratories AB YoY EBITDA Growth Historical Data

The historical data trend for RaySearch Laboratories AB's YoY EBITDA Growth can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

RaySearch Laboratories AB YoY EBITDA Growth Chart

RaySearch Laboratories AB Annual Data

Trend

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Dec24

YoY EBITDA Growth

Get a 7-Day Free Trial

-4.62

-14.92

51.34

20.46

31.46

RaySearch Laboratories AB Quarterly Data
	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24	Mar25
YoY EBITDA Growth	Get a 7-Day Free Trial															93.94	340.00	134.67	54.76	67.97

RaySearch Laboratories AB YoY EBITDA Growth Calculation

YoY EBITDA Growth is the percentage change of EBITDA per Share over the past twelve months.

RaySearch Laboratories AB's YoY EBITDA Growth for the fiscal year that ended in Dec. 2024 is calculated as:

	YoY EBITDA Growth (A: Dec. 2024 )
=	(EBITDA per Share (A: Dec. 2024 )	-	EBITDA per Share (A: Dec. 2023 ))	/	\| EBITDA per Share (A: Dec. 2023 ) \|
=	(1.517	-	1.154)	/	\| 1.154 \|
=	31.46 %

RaySearch Laboratories AB's YoY EBITDA Growth for the quarter that ended in Mar. 2025 is calculated as:

	YoY EBITDA Growth (Q: Mar. 2025 )
=	(EBITDA per Share (Q: Mar. 2025 )	-	EBITDA per Share (Q: Mar. 2024 ))	/	\| EBITDA per Share (Q: Mar. 2024 )) \|
=	(0.215	-	0.128)	/	\| 0.128 \|
=	67.97 %

RaySearch Laboratories AB YoY EBITDA Growth Related Terms

Thank you for viewing the detailed overview of RaySearch Laboratories AB's YoY EBITDA Growth provided by GuruFocus.com. Please click on the following links to see related term pages.

RaySearch Laboratories AB Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Healthcare Providers & Services » RaySearch Laboratories AB (OTCPK:RSLBF) » Definitions » YoY EBITDA Growth

Comparable Companies

Traded in Other Exchanges

RAY B:Sweden RAYBs:UK 0GRZ:UK 27R:Germany

Address

Eugeniavagen 18C, P.O. Box 3297, Stockholm, SWE, 113 68

Website

https://www.raysearchlabs.com

RaySearch Laboratories AB is a Sweden-based medical technology company. The company develops advanced software solutions for improved cancer treatment. The company develops and markets the RayStation* treatment planning system and RayCare* oncology information system to clinics all over the world and distributes products through licensing agreements with medical technology companies. Its geographic segments consist of Sweden, North America, Asia, Europe and the rest of the world. The company generates majority of its sales from the North America.